What Researchers Did
Researchers investigated the effect of hyperbaric oxygenation (HBO) in 64 patients with parkinsonism of various etiologies.
What They Found
A beneficial effect was observed in 55 out of 64 patients (86%) who received daily HBO sessions. Treatment outcomes were more favorable in patients with vascular parkinsonism, those under 65 years old, and individuals with a disease duration of 1-5 years, with the akinetic-rigid syndrome showing greater regression than trembling hyperkinesis.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Russia and does not involve Canadian researchers or patients.
Study Limitations
A key limitation of this study is the absence of a control group, which prevents definitive conclusions about the efficacy of hyperbaric oxygenation compared to standard care or placebo.